Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy Recalls

All product recalls associated with Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy.

Get alerts for this brand

Recall Summary

Total Recalls

597

Past Year

Class I (Serious)

Most Recent

May 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 61–80 of 597 recalls

Tacrolimus Suspension (Valor Compounding) – Subpotent Drug (2022)

Subpotent drug

Class IHigh

FDAApr 15, 2022CA• Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy

Symjepi Epinephrine Injection (Adamis) – Delivery System Defect (2022)

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Class IHigh

FDAMar 21, 2022Nationwide• Adamis Pharmaceuticals Corporation

SYMJEPI Epinephrine Injection (Adamis) – Potential Needle Clogging (2022)

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Class I

1 2 345 6...30

Page 4 of 30Next

High

FDAMar 21, 2022Nationwide• Adamis Pharmaceuticals Corporation

THERAKOS CELLEX Kit (Mallinckrodt) – Shipping Case Issue (2021)

This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.

FDADec 10, 2021Nationwide• Mallinckrodt Pharmaceuticals Ireland Ltd College Business & Technology Park Blanchardstown Road North Dublin

Hydroxocobalamin Injection (Talon) – Sterility Concern (2021)

Lack of assurance of sterility

Stay Informed

Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy Recalls

Recall Summary

Tacrolimus Suspension (Valor Compounding) – Subpotent Drug (2022)

Symjepi Epinephrine Injection (Adamis) – Delivery System Defect (2022)

SYMJEPI Epinephrine Injection (Adamis) – Potential Needle Clogging (2022)

THERAKOS CELLEX Kit (Mallinckrodt) – Shipping Case Issue (2021)

Hydroxocobalamin Injection (Talon) – Sterility Concern (2021)

MIC B Complex Hydroxocobalamin Injection (Talon) – sterility concern (2021)

Testosterone Cypionate with Anastrozole (Talon Compounding) – sterility concern (2021)

B Complex Injection (Talon) – Sterility Assurance Lack (2021)

Alprostadil Injection (Talon) – Sterility Assurance Lack (2021)

Tri-Test 200 Injection (Talon) – Sterility Assurance Lack (2021)

Test Cypionate Combination (Talon) – Sterility Assurance Lack (2021)

Testosterone Cypionate Injection (Talon) – Sterility Assurance Lack (2021)

Test Cypionate Combination (Talon) – Sterility Assurance Lack (2021)

IC B Complex Injection (Talon) – Sterility Assurance Lack (2021)

Tri-Mix Papaverine Injection (Talon) – Sterility Assurance Lack (2021)

TRI-MIX Papaverine (Talon Compounding) – Sterility Concern (2021)

Sermorelin Acetate/Ipamorelin (Talon) – Sterility Risk (2021)

TRI-MIX Papaverine (Talon Compounding) – Sterility Concern (2021)

TRI-MIX Papaverine (Talon Compounding) – Sterility Risk (2021)

MIC B12 Injectable (Talon Compounding) – sterility concern (2021)